| Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors MG Mazza, R De Lorenzo, C Conte, S Poletti, B Vai, I Bollettini, ... Brain, behavior, and immunity 89, 594-600, 2020 | 2078 | 2020 |
| Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up MG Mazza, M Palladini, R De Lorenzo, C Magnaghi, S Poletti, R Furlan, ... Brain, behavior, and immunity 94, 138-147, 2021 | 507 | 2021 |
| Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis B Vai, MG Mazza, CD Colli, M Foiselle, B Allen, F Benedetti, A Borsini, ... The Lancet Psychiatry 8 (9), 797-812, 2021 | 335 | 2021 |
| Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: a meta-analysis MG Mazza, S Lucchi, AGM Tringali, A Rossetti, ER Botti, M Clerici Progress in Neuro-Psychopharmacology and Biological Psychiatry 84, 229-236, 2018 | 317 | 2018 |
| Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study R De Lorenzo, C Conte, C Lanzani, F Benedetti, L Roveri, MG Mazza, ... PloS one 15 (10), e0239570, 2020 | 244 | 2020 |
| Prevalence of co‐occurring psychiatric disorders in adults and adolescents with intellectual disability: A systematic review and meta‐analysis MG Mazza, A Rossetti, G Crespi, M Clerici Journal of Applied Research in Intellectual Disabilities 33 (2), 126-138, 2020 | 202 | 2020 |
| Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment MG Mazza, M Palladini, S Poletti, F Benedetti CNS drugs 36 (7), 681-702, 2022 | 183 | 2022 |
| Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio in non-affective psychosis: a meta-analysis and systematic review MG Mazza, S Lucchi, A Rossetti, M Clerici The World Journal of Biological Psychiatry 21 (5), 326-338, 2020 | 162 | 2020 |
| Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life S Poletti, M Palladini, MG Mazza, R De Lorenzo, R Furlan, F Ciceri, ... European archives of psychiatry and clinical neuroscience, 1-10, 2022 | 126 | 2022 |
| Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: a multimodal magnetic resonance imaging study F Benedetti, M Palladini, M Paolini, E Melloni, B Vai, R De Lorenzo, ... Brain, behavior, & immunity-health 18, 100387, 2021 | 117 | 2021 |
| One-year mental health outcomes in a cohort of COVID-19 survivors MG Mazza, M Palladini, R De Lorenzo, B Bravi, S Poletti, R Furlan, ... Journal of psychiatric research 145, 118-124, 2022 | 102 | 2022 |
| Uric acid levels in subjects with bipolar disorder: a comparative meta-analysis F Bartoli, C Crocamo, MG Mazza, M Clerici, G Carra Journal of Psychiatric Research 81, 133-139, 2016 | 93 | 2016 |
| A peripheral inflammatory signature discriminates bipolar from unipolar depression: a machine learning approach S Poletti, B Vai, MG Mazza, R Zanardi, C Lorenzi, F Calesella, S Cazzetta, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 105, 110136, 2021 | 92 | 2021 |
| Cross-sectional study of neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in mood disorders MG Mazza, AGM Tringali, A Rossetti, RE Botti, M Clerici General hospital psychiatry 58, 7-12, 2019 | 90 | 2019 |
| Diabetes mellitus and acute myocardial infarction: impact on short and long-term mortality V Milazzo, N Cosentino, S Genovese, J Campodonico, M Mazza, ... Diabetes: from Research to Clinical Practice: Volume 4, 153-169, 2021 | 80 | 2021 |
| Rapid response to selective serotonin reuptake inhibitors in post-COVID depression MG Mazza, R Zanardi, M Palladini, P Rovere-Querini, F Benedetti European Neuropsychopharmacology 54, 1-6, 2022 | 68 | 2022 |
| Can cytokine blocking prevent depression in COVID-19 survivors? F Benedetti, M Mazza, G Cavalli, F Ciceri, L Dagna, P Rovere-Querini Journal of Neuroimmune Pharmacology 16, 1-3, 2021 | 65 | 2021 |
| An in-hospital pathway for acute coronary syndrome patients during the COVID-19 outbreak: initial experience under real-world suboptimal conditions N Cosentino, E Assanelli, L Merlino, M Mazza, AL Bartorelli, G Marenzi Canadian Journal of Cardiology 36 (6), 961-964, 2020 | 51 | 2020 |
| Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder F Benedetti, S Poletti, B Vai, MG Mazza, C Lorenzi, S Brioschi, V Aggio, ... European Neuropsychopharmacology 42, 35-44, 2021 | 44 | 2021 |
| Prevalence, trajectory over time, and risk factor of post-COVID-19 fatigue MG Mazza, M Palladini, G Villa, R De Lorenzo, PR Querini, F Benedetti Journal of psychiatric research 155, 112-119, 2022 | 42 | 2022 |
